| Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook |
Globe Newswire |
05/05 |
07:03 |
| Fiserv Reports First Quarter 2026 Results |
Globe Newswire |
05/05 |
07:01 |
| Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
Globe Newswire |
05/05 |
07:01 |
| BellRing Brands Reports Results for the Second Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook |
Globe Newswire |
05/05 |
07:00 |
| Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at Digestive Disease Week |
Globe Newswire |
05/05 |
07:00 |
| GlobalFoundries Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/05 |
07:00 |
| Editas Medicine Announces First Quarter 2026 Results and Business Updates |
Globe Newswire |
05/05 |
07:00 |
| Shoals Technologies Group, Inc. Reports Financial Results for First Quarter 2026 |
Globe Newswire |
05/05 |
07:00 |
| First Watch Restaurant Group, Inc. Reports Q1 2026 Financial Results |
Globe Newswire |
05/05 |
07:00 |
| Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates |
Globe Newswire |
05/05 |
07:00 |
| OTC Markets Group Welcomes CoTec Holdings Corp. to OTCQX |
Globe Newswire |
05/05 |
07:00 |
| Dupixent® (dupilumab) Demonstrates Improved Esophageal Function in Eosinophilic Esophagitis (EoE) Phase 4 Trial |
Globe Newswire |
05/05 |
07:00 |
| Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights |
Globe Newswire |
05/05 |
07:00 |
| Colliers Reports First Quarter Results |
Globe Newswire |
05/05 |
07:00 |
| Virtu Financial Connects to zerohash, Further Deepening Institutional-Grade Liquidity for Digital Assets |
Globe Newswire |
05/05 |
07:00 |
| FactSet Increases Dividend |
Globe Newswire |
05/05 |
07:00 |
| The Devon Group Names Kate Achille as Chief Executive Officer |
Globe Newswire |
05/05 |
07:00 |
| Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts |
Globe Newswire |
05/05 |
07:00 |
| Electra Therapeutics Announces First Patient Dosed in Phase 1 Study of Ipsoprubart (ELA026) in T Cell Malignancies |
Globe Newswire |
05/05 |
07:00 |
| Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance |
Globe Newswire |
05/05 |
07:00 |
| Eupraxia Pharmaceuticals Reports EREFS Data from its Ongoing Phase 1b/2a RESOLVE Trial in Eosinophilic Esophagitis at Digestive Disease Week (DDW) |
Globe Newswire |
05/05 |
07:00 |
| NeurAxis to Host First Quarter 2026 Results and Business Update Call on Tuesday, May 12, 2026 |
Globe Newswire |
05/05 |
07:00 |
| Mike Lindell Media Corp. - LindellTV (OTC:) MLMC Announces Another Milestone as Part of the Company Short-Term Goals Strategy by Adding Sentry H20 |
Globe Newswire |
05/05 |
07:00 |
| ANOTHER QUARTER OF STRONG MIX - 2026 GUIDANCE CONFIRMED |
Globe Newswire |
05/05 |
06:53 |
| TopBuild Reports First Quarter 2026 Results |
Globe Newswire |
05/05 |
06:45 |
